Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Because sermorelin raises IGF-1, the theoretical concern shared with all GH-axis stimulants applies: chronically elevated IGF-1 has been associated epidemiologically with increased cancer risk in some observational data, though causality is unproven and short-term use at physiological doses is not the same as pharmacological IGF-1 elevation
Explosive market growth for weight-loss medications The GLP-1 market is booming: $26 billion in sales in 2024, projected to hit $100470 billion annually by 2032, dominated by just two pharmaceutical giants: Novo Nordisk and Eli Lilly
Typical responses are localized irritation at injection sites, mild allergies, and brief flu-like symptoms
It holds promise in various disease conditions, particularly in inflammatory bowel disease (IBD) treatment, where it has shown substantial
US$ 28.87
US$ 26.88
US$ 21.07
US$ 21.19
US$ 21.73
US$ 27.25
US$ 27.92
US$ 21.26
US$ 29.90
